Current benefits from inhaled LABA such as salmeterol and formoterol ... guidelines list the addition of a LTRA to ICS as an alternative to the preferred treatment of adding a LABA to ICS.

no alternative pulmonary diagnoses and a prescription of a maintenance inhaler containing ICS-LABA or ICS alone. The team reviewed these charts to ensure patients met eligibility criteria.

Salmeterol is a selective LABA. The effects ... treat immediately with an inhaled, short-acting bronchodilator; discontinue Serevent Diskus immediately and institute alternative therapy.

No major differences in adverse effects were observed between these inhalers and their alternatives ... (LAMA), and a long-acting beta-agonist (LABA), was found to offer comparable or incremental ...

In such instances, a daily inhaled corticosteroid may be prescribed on its own, after which a LABA may be added if needed. LABAs are never used on their own to treat asthma. While pulmonary ...

The FDA has requested five large clinical trials to evaluate fixed-dose ICS–LABA products with the primary outcome of life-threatening asthma exacerbation or death. The results will not be ...